FDA approves first COVID-19 drug: antiviral remdesivir

(Photo Supplied/CDC)

WASHINGTON (AP): U.S. regulators have approved the first drug to treat COVID-19.

Remdesivir is an antiviral medicine given through an IV. Its maker, Gilead Sciences Inc., said Thursday that the drug is approved for people at least 12 years old who need hospitalization for their coronavirus infection.

The company is calling it Veklury. A large U.S. study found it cut the time to recovery by five days — from 15 days to 10 on average.

It has been authorized for use on an emergency basis since spring. It works by inhibiting a substance the virus uses to make copies of itself.


  1. Step in the right direction. Viruses are more difficult than bacteria to kill and the SARS-CoV 2 is more difficult than most. Historically the development of emergency therapies has taken longer that this time around and vaccine development has taken years instead of months. The scientific community somehow has been able to put together a unique team work environment resulting in amazing progress.


Please enter your comment!
Please enter your name here